Marshall Wace’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
322,110
-71,902
| -18% | -$173K | ﹤0.01% | 1832 |
|
|
2025
Q1 | $871K | Sell |
394,012
-2,384,485
| -86% | -$5.27M | ﹤0.01% | 1744 |
|
|
2024
Q4 | $15.1M | Buy |
2,778,497
+2,763,072
| +17,913% | +$15.1M | 0.02% | 592 |
|
|
2024
Q3 | $128K | Sell |
15,425
-3,989,459
| -100% | -$33.2M | ﹤0.01% | 2176 |
|
|
2024
Q2 | $28.7M | Sell |
4,004,884
-824,862
| -17% | -$5.91M | 0.04% | 358 |
|
|
2024
Q1 | $41.9M | Buy |
4,829,746
+2,182,413
| +82% | +$18.9M | 0.06% | 262 |
|
|
2023
Q4 | $17.3M | Buy |
2,647,333
+1,889,796
| +249% | +$12.4M | 0.03% | 441 |
|
|
2023
Q3 | $7.58M | Buy |
757,537
+703,612
| +1,305% | +$7.04M | 0.02% | 669 |
|
|
2023
Q2 | $670K | Sell |
53,925
-1,699,014
| -97% | -$21.1M | ﹤0.01% | 1496 |
|
|
2023
Q1 | $24.6M | Sell |
1,752,939
-987,757
| -36% | -$13.8M | 0.05% | 341 |
|
|
2022
Q4 | $39.2M | Buy |
2,740,696
+663,660
| +32% | +$9.5M | 0.09% | 223 |
|
|
2022
Q3 | $53M | Buy |
2,077,036
+1,538,680
| +286% | +$39.3M | 0.12% | 160 |
|
|
2022
Q2 | $15.3M | Buy |
538,356
+37,144
| +7% | +$1.06M | 0.03% | 551 |
|
|
2022
Q1 | $17.7M | Buy |
501,212
+106,404
| +27% | +$3.75M | 0.03% | 507 |
|
|
2021
Q4 | $16.5M | Sell |
394,808
-1,093,208
| -73% | -$45.8M | 0.03% | 525 |
|
|
2021
Q3 | $73M | Buy |
1,488,016
+1,414,052
| +1,912% | +$69.4M | 0.3% | 38 |
|
|
2021
Q2 | $3.09M | Sell |
73,964
-163,221
| -69% | -$6.81M | 0.01% | 950 |
|
|
2021
Q1 | $8.45M | Sell |
237,185
-125,795
| -35% | -$4.48M | 0.04% | 498 |
|
|
2020
Q4 | $10.2M | Buy |
+362,980
| New | +$10.2M | 0.06% | 314 |
|